FGFR: Proof-of-concept study of AZD4547 in patients with FGFR1 or FGFR2 amplified tumours.

被引：0
|
作者：
Smyth, Elizabeth Catherine
Turner, Nicholas C.
Popat, Sanjay
Morgan, Shethah
Owen, Kate
Gillbanks, Angela
Jain, Vikram Kumar
Cunningham, David
机构：
[1] Royal Marsden Hosp NHS Fdn Trust, London, England
[2] AstraZeneca, Macclesfield, Cheshire, England
[3] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2626
引用
收藏
页数：1
相关论文
共 50 条
  • [21] ASSOCIATION STUDY OF FIVE MUTATION IN FGFR1 AND FGFR2 GENES IN INDIAN CHILDREN WITH CRANIOSYNOSTOSIS
    Pandey, Rajeev Kumar
    Ali, Abid
    Bajpai, Minu
    Gayan, Sukanya
    Singh, Amit
    GENETIKA-BELGRADE, 2013, 45 (03): : 881 - 893
  • [22] Expression of FGFR1, FGFR2 and FGFR3 during early neural development in the chick embryo
    Walshe, J
    Mason, I
    MECHANISMS OF DEVELOPMENT, 2000, 90 (01) : 103 - 110
  • [23] Fgfr1 and Fgfr2 signaling in the osteoprogenitor lineage is essential for skeletal growth and development
    Karuppaiah, Kannan
    Yu, Kai
    Smith, Craig
    Ornitz, David
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S493 - S493
  • [24] The essential role of FGFR1 and FGFR2 for the generation of oligodendrocyte progenitors in the embryonic forebrain
    Furusho, M.
    Kaga, Y.
    Bryant, M.
    Hebert, J.
    Bansal, R.
    JOURNAL OF NEUROCHEMISTRY, 2008, 104 : 47 - 47
  • [25] Expression and clinical significance of FGFR1 and FGFR2 in laryngeal squamous cell carcinoma
    Hu, Mengdie
    Zhang, Shujun
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (09) : 3222 - 3234
  • [26] Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses
    Passos-Bueno, MR
    Sertié, AL
    Richieri-Costa, A
    Alonso, LG
    Zatz, M
    Alonso, N
    Brunoni, D
    Ribeiro, SFM
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 78 (03): : 237 - 241
  • [27] Expression of fibroblast growth factor receptors (FGFR1, FGFR2, FGFR3) in the developing head and face
    Wilke, TA
    Gubbels, S
    Schwartz, J
    Richman, JM
    DEVELOPMENTAL DYNAMICS, 1997, 210 (01) : 41 - 52
  • [28] Are FGFR1 and FGFR2 Activated By Novel DNAJB1-PRKACA in Fibrolamellar Carcinoma?
    Torbenson, Michael
    Graham, Rondell
    Greipp, Patricia
    Fritcher, Emily Barr
    Kipp, Benjamin
    Garcia, Joaquin
    LABORATORY INVESTIGATION, 2015, 95 : 424A - 425A
  • [29] Are FGFR1 and FGFR2 Activated By Novel DNAJB1-PRKACA in Fibrolamellar Carcinoma?
    Torbenson, Michael
    Graham, Rondell
    Greipp, Patricia
    Fritcher, Emily Barr
    Kipp, Benjamin
    Garcia, Joaquin
    MODERN PATHOLOGY, 2015, 28 : 424A - 425A
  • [30] Selective FGFR inhibitor, AZD4547, modulates bone microenvironment by suppressing RNAKL/M-CSF/Osteocalcine induced osteoclastogenesis in FGFR-amplified breast cancer
    Choi, Y. J.
    Kang, J.
    Lee, H. J.
    Jo, U.
    Park, S. I.
    Bae, J. W.
    Park, K. H.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S118 - S119
12345